🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

63,60 USD

Máx. histórico

108,06

1031 días

Split 1:6 del 25/06/2013

Caída desde máximo

-41,14%

Rango 52 semanas

58,05 – 88,31

Variación hoy

+2,07%

Cierre anterior

62,31

Rango de hoy

60,98 – 64,95

Volumen hoy

2.686.320

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,37%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 3 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/03/2009 10,50 12,00 10,14 12,00 +13,64% 17,71% 12.583
11/03/2009 11,76 12,00 10,32 10,56 -11,56% 14,29% 13.167
10/03/2009 10,80 12,06 10,20 11,94 +6,99% 17,22% 206.967
09/03/2009 12,18 12,30 11,16 11,16 -9,71% 9,36% 30.983
06/03/2009 11,52 12,48 11,46 12,36 +8,42% 8,85% 35.267
05/03/2009 11,04 11,64 11,04 11,40 +3,26% 5,43% 39.183
04/03/2009 9,36 11,10 8,82 11,04 +20,26% 24,36% 15.883
03/03/2009 8,88 9,60 8,82 9,18 +5,52% 8,78% 13.050
02/03/2009 9,24 9,66 8,34 8,70 -8,23% 14,29% 14.267
27/02/2009 11,22 11,58 9,42 9,48 -14,59% 19,25% 20.933
26/02/2009 12,12 12,78 11,04 11,10 -7,50% 14,36% 30.100
25/02/2009 14,10 14,10 11,46 12,00 -10,71% 18,72% 51.433
24/02/2009 12,18 13,56 11,82 13,44 +12,00% 14,29% 45.783
23/02/2009 11,94 12,24 11,70 12,00 +2,04% 4,52% 15.250
20/02/2009 11,70 12,00 11,64 11,76 +0,51% 3,08% 38.517
19/02/2009 12,24 12,30 11,70 11,70 -2,50% 4,90% 30.900
18/02/2009 12,24 12,42 12,00 12,00 +0,00% 3,43% 15.517
17/02/2009 12,30 12,60 11,76 12,00 -2,91% 6,83% 22.567
13/02/2009 12,48 12,72 12,00 12,36 -0,48% 5,77% 23.183
12/02/2009 12,00 12,54 11,88 12,42 +3,50% 5,50% 55.633
11/02/2009 12,42 12,60 12,00 12,00 -0,50% 4,83% 56.233
10/02/2009 12,54 13,14 11,58 12,06 -4,74% 12,44% 54.750
09/02/2009 12,54 12,90 11,94 12,66 +0,96% 7,66% 25.883
06/02/2009 11,64 12,60 11,64 12,54 +7,73% 8,25% 48.833
05/02/2009 11,82 12,06 11,46 11,64 -2,02% 5,08% 43.767
04/02/2009 12,72 12,72 11,70 11,88 -6,16% 8,02% 30.400
03/02/2009 13,32 13,32 12,06 12,66 -4,09% 9,46% 43.883
02/02/2009 12,60 13,56 12,42 13,20 +3,77% 9,05% 28.083
30/01/2009 13,20 13,74 12,66 12,72 +0,47% 8,18% 13.900
29/01/2009 13,26 13,32 12,66 12,66 -6,22% 4,98% 12.550